Mepenzolate
Risk Factor: C
Class: AUTONOMICS
/ Parasympatholytics (Anticholinergics)
Contents of this page:
Fetal Risk Summary
Breast Feeding Summary
References
Questions and Answers
Fetal Risk Summary
Mepenzolate is an anticholinergic quaternary ammonium bromide. In a large prospective study, 2,323 patients were exposed to this class of drugs during the 1st trimester, 1 of whom took mepenzolate (1). A possible association was found between the total group and minor malformations.
Breast Feeding Summary
No data are available (see also Atropine).
References
-
Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group, 1977:34653.
